Demant A/S: Financial calendar 2026
Company announcement no 2025-14 3 December 2025
Financial calendar 2026
|
21 January |
Deadline for submission of items for the agenda of the annual |
|
13 January to 2 February
|
Quiet period prior to publication of Annual Report 2025 |
|
3 February
|
Annual Report 2025 |
|
5 March
|
Annual general meeting |
|
15 April to 5 May
|
Quiet period prior to publication of Interim Management Statement |
|
5 May
|
Interim Management Statement for Q1 2026 |
|
22 July to 11 August
|
Quiet period prior to publication of Interim Report 2026 |
|
11 August
|
Interim Report 2026 |
|
14 October to 3 November
|
Quiet period prior to publication of Interim Management Statement |
|
3 November
|
Interim Management Statement for Q3 2026 |
* Please note that if a shareholder would like to have a specific item included on the agenda for the annual general meeting on 5 March 2026, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 21 January 2026.
|
Further information: Peter Pudselykke, Head of Investor Relations Phone +45 2830 7638
Phone +45 5350 0114 |
Contacts
Henrik Axel Lynge Buchter
External Communication Manager
Corporate Communication & Sustainability
Tel:
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Alternative languages
Attachments
Subscribe to our company announcements
Keep up to date with our company announcements by subscribing.
Visit our pressroom and see more company announcements from us.
Our pressroom